Biogen

News

Hope for Alzheimer’s treatment after promising study results

Biogen and Eisai said their latest clinical study confirmed the amyloid hypothesis and might lead to the first drug successfully treating Alzheimer’s disease, instantly bumping their share

News

Bottles of prescription medicine in a pile. This collection of pill bottles is symbolic of the many medications senior adults and chronically ill people take.

PTC shares soar after SMA drug data impresses market

After failing three times to bring their Duchenne therapy to the US market, PTC Therapeutics might be on verge of a breakthrough in the SMA field.

News

Biogen’s Alzheimer’s drug, elenbecestat, shows early promise

A trial of Biogen’s Alzheimer’s disease drug elenbecestat has had promising results in mild to moderate forms of the disease.

News

Closeup of X-ray photography of human brain

vTv's azeliragon is latest Alzheimer's drug failure

vTv to stop all studies after STEADFAST trial failure

AbbVie

Biogen gets go-ahead for EU Humira launch in October

But deal with Samsung prevents US launch until mid-2023

News

Dangerous inflammation prompts worldwide withdrawal of MS dr...

Biogen and AbbVie have announced the voluntary withdrawal of their multiple sclerosis drug Zinbryta from all markets worldwide following dangerous brain inflammation in seven patients in Eu

Hope for Alzheimer’s treatment after promising study results

PTC shares soar after SMA drug data impresses market

Biogen’s Alzheimer’s drug, elenbecestat, shows early promise

vTv's azeliragon is latest Alzheimer's drug failure

Biogen gets go-ahead for EU Humira launch in October

Dangerous inflammation prompts worldwide withdrawal of MS dr...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Biogen

Editor's Picks